Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

N Acetyl Cysteine Can Decrease the Progression of Renal Disease in Cystinosis Patients

NCT01614431 is registered in ClinicalTrials.gov with University of Sao Paulo as lead sponsor.

NCT NCT01614431
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01614431 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
N Acetyl Cysteine Can Decrease the Progression of Renal Disease in Cystinosis Patients
Lead sponsor
University of Sao Paulo
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2011
Completion date
May 31, 2012
Enrollment
23 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cystinosis, renal disease